Related Experiment Videos
The importance of timing of thrombolytic therapy as shown in clinical trials
1Department of Medicine, University of Florida, Gainesville 32610.
Insights
Rapid reperfusion therapy is crucial for acute myocardial infarction. Shorter treatment times preserve more heart muscle, improving patient outcomes after coronary artery occlusion.
Area of Science:
- Cardiology
- Emergency Medicine
- Cardiovascular Research
Background:
- Acute coronary artery occlusion leads to myocardial ischemia and necrosis if not treated promptly.
- Myocardial damage in acute myocardial infarction is time-dependent, with irreversible injury occurring within 30-40 minutes without reperfusion.
Purpose of the Study:
- To emphasize the critical time-dependent nature of myocardial damage in acute myocardial infarction.
- To highlight the importance of early reperfusion intervention for preserving left ventricular myocardium.
Main Methods:
- Review of data from large, controlled clinical trials, including GISSI-1, TIMI-I, and ECSG.
- Analysis of the relationship between symptom onset, treatment initiation, and myocardial preservation.
Main Results:
- Strong evidence indicates that reduced time to thrombolytic therapy correlates with greater myocardial salvage.
- Earlier intervention significantly increases the recovery of injured, but not irreversibly damaged, heart tissue.
Conclusions:
- The time to reperfusion is a critical determinant of myocardial damage extent in acute myocardial infarction.
- Prompt initiation of treatment following coronary artery occlusion is essential for improving patient outcomes and preserving cardiac function.
Abstract:
With the onset of acute coronary artery occlusion, which occurs as a result of thrombus, the development of myocardial ischemia and reversible ischemic injury leads to a wavefront of necrosis if reperfusion does not occur within 30 to 40 min. Thus, the magnitude and extent of myocardial damage, occurring during acute myocardial infarction are time-dependent. It follows that the sooner reperfusion intervention is instituted after the onset of occlusion, the greater the magnitude of recovery of injured, but not irreversibly damaged, left ventricular myocardium. Thus, earlier treatment should have an important effect on outcome. Data are available from several large, controlled trials to support this concept. These trials include the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI-1), the Thrombolysis in Myocardial Infarction (TIMI-I), and the European Cooperative Study Group (ECSG) studies. Strong evidence suggests that the shorter the time between onset of symptoms and institution of thrombolytic therapy, the greater the amount of myocardium preserved.